Table 4.
Strata for Hypertension and Heart Problem Analysis | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
Variables | Stratum 1 [.02, .06) | Stratum 2 [.06, .12) | Stratum 3 [.12, .19) | Stratum 4 [.19, .25) | Stratum 5 [.25, .50) | Stratum 6 [.50, .75) | Stratum 7 [.75, .88) | ||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | |
Age | 49.263 | 44.000 | 48.872 | 50.621 | 50.225 | 50.567 | 47.525 | 49.910 | 48.008 | 45.115 | 45.991 | 45.375 | 45.129 | 45.676 | 45.368 | 43.467 | 42.487 | 42.828 | 40.000 | 40.621 | 40.462 |
| |||||||||||||||||||||
Non-white | 0.156 | 0.222 | 0.161 | 0.156 | 0.147 | 0.155 | 0.135 | 0.210 | 0.150 | 0.065 | 0.108 | 0.078 | 0.106 | 0.096 | 0.101 | 0.086 | 0.061 | 0.070 | 0.150 | 0.034 | 0.064 |
| |||||||||||||||||||||
Female | 0.804 | 0.722 | 0.798 | 0.615 | 0.588 | 0.611 | 0.533 | 0.430 | 0.512 | 0.492 | 0.441 | 0.477 | 0.401 | 0.392 | 0.397 | 0.438 | 0.447 | 0.444 | 0.150 | 0.172 | 0.167 |
| |||||||||||||||||||||
Sample Size | 224 | 18 | 242 | 646 | 102 | 748 | 394 | 100 | 494 | 262 | 111 | 373 | 379 | 293 | 672 | 105 | 197 | 302 | 20 | 58 | 78 |
| |||||||||||||||||||||
Strata for Mortality Analysis | |||||||||||||||||||||
| |||||||||||||||||||||
Variables | Stratum 1 [.02, .08) | Stratum 2 [.08, .17) | Stratum 3 [.17, .25) | Stratum 4 [.25, .33) | Stratum 5 [.33, .67) | Stratum 6 [.67, .88) | |||||||||||||||
|
|
|
|
|
|
||||||||||||||||
d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | d = 0 | d = 1 | B | ||||
| |||||||||||||||||||||
Age | 50.593 | 47.049 | 50.300 | 49.261 | 51.103 | 49.574 | 45.124 | 46.014 | 45.379 | 45.305 | 46.103 | 45.638 | 44.472 | 44.035 | 44.248 | 42.156 | 41.682 | 41.805 | |||
| |||||||||||||||||||||
Non-white | 0.145 | 0.195 | 0.149 | 0.150 | 0.172 | 0.153 | 0.094 | 0.131 | 0.105 | 0.116 | 0.118 | 0.117 | 0.086 | 0.078 | 0.082 | 0.156 | 0.031 | 0.063 | |||
| |||||||||||||||||||||
Female | 0.749 | 0.610 | 0.738 | 0.551 | 0.538 | 0.549 | 0.508 | 0.428 | 0.485 | 0.426 | 0.346 | 0.393 | 0.390 | 0.452 | 0.422 | 0.333 | 0.295 | 0.305 | |||
| |||||||||||||||||||||
Sample Size | 455 | 41 | 496 | 709 | 145 | 854 | 362 | 145 | 507 | 190 | 136 | 326 | 269 | 283 | 552 | 45 | 129 | 174 |
Note: Means are presented, where d indicates the treatment condition and B represents the overall mean for each propensity score stratum. t tests indicate that mean propensity scores did not differ between non-treated (d = 0) and treated (d = 1) respondents for any of the strata in Table 4 (p < .001; see Brand and Xie 2010:281).